Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Gut. 2013 Oct;62(10):1425-32. doi: 10.1136/gutjnl-2011-301647. Epub 2012 Aug 21.
After endoscopic submucosal dissection (ESD) of early gastric cancer (EGC), patients are at high risk for synchronous or metachronous multiple gastric cancers.
To elucidate the time at which multiple cancers develop and to determine whether scheduled endoscopic surveillance might control their development.
A multicentre retrospective cohort study from 12 hospitals was conducted. Patients with EGC who underwent ESD with en bloc margin-negative curative resection were included. Synchronous cancer was classified as concomitant cancer or missed cancer. The cumulative incidence of metachronous cancers and overall survival rate were calculated using the Kaplan-Meier method.
From April 1999 to December 2010, 1258 patients met the inclusion criteria. Synchronous or metachronous multiple cancers were detected in 175 patients (13.9%) during a mean of 26.8 months. Among the 110 synchronous cancers, 21 were missed at the time of the initial ESD. Many of the missed lesions existed in the upper third of the stomach and the miss rate was associated with the endoscopist's inexperience (<500 oesophagogastroduodenoscopy cases). The cumulative incidence of metachronous cancers increased linearly and the mean annual incidence rate was 3.5%. The incidence rate did not differ between patients with or without Helicobacter pylori eradication. Four lesions (0.32%) were detected as massively invading cancers during the follow-up.
Nineteen per cent of synchronous cancers were not detected until the initial ESD. The incidence rate of metachronous cancer after ESD was constant. Scheduled endoscopic surveillance showed that almost all recurrent lesions were treatable by endoscopic resection.
内镜黏膜下剥离术(ESD)治疗早期胃癌(EGC)后,患者发生同步或异时性多发性胃癌的风险较高。
阐明多发性癌症发生的时间,并确定定期内镜监测是否可以控制其发展。
来自 12 家医院的多中心回顾性队列研究。纳入接受整块边缘阴性治愈性切除的 EGC 患者。将同期癌分为伴发癌或漏诊癌。采用 Kaplan-Meier 法计算异时性癌的累积发生率和总生存率。
1999 年 4 月至 2010 年 12 月,符合纳入标准的患者共 1258 例。在平均 26.8 个月的时间内,175 例患者(13.9%)发现了同步或异时性多发性癌症。在 110 例同时性癌症中,21 例在初次 ESD 时漏诊。许多漏诊病变位于胃的上三分之一,漏诊率与内镜医生的经验不足有关(<500 例上消化道内镜检查病例)。异时性癌症的累积发生率呈线性增加,年平均发生率为 3.5%。在 Hp 根除治疗组和未治疗组中,发病率没有差异。在随访过程中,有 4 个病变(0.32%)被检出为巨侵润性癌症。
19%的同步癌在初次 ESD 时未被发现。ESD 后异时性癌症的发生率是恒定的。定期内镜监测显示,几乎所有复发性病变都可以通过内镜切除治疗。